A national survey on knowledge and perceptions of senior medical students in Australia about generic medicines

Hassali, Mohamed Azmi Ahmad; Stewart, Kay; Kong, David C M

doi:10.5694/j.1326-5377.2008.tb01543.x

Topics

To the Editor: In Australia, the rising cost of the Pharmaceutical Benefits Scheme (a comprehensive system for subsidising prescription medicines for the whole population) has led to the Australian Government instituting a number of cost-saving strategies.

1 Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
2 Department of Pharmacy Practice, Victorian College of Pharmacy, Monash University, Melbourne, VIC.

Correspondence: azmihassali@usm.my

1. McGavock H. Generic substitution: issues relating to the Australian experience. Pharmacoepidemiol Drug Saf 2001; 10: 555-556.
2. Birkett DJ. Generics — equal or not? Aust Prescr 2003; 26: 85-87.
3. Salmivaara AH, Huupponen R, Klaukka T, Hoppu K. Focusing on changing clinical practice to enhance rational prescribing — collaboration and networking enable comprehensive approaches. Health Policy 2003; 66: 1-10.
4. Armstrong D, Reyburn H, Jones R. A study of general practitioners’ reasons for changing their prescribing behaviour. BMJ 1996; 312: 949-952.
5. Majumdar SR, Tsuyuki RT, McAlister FA. Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial. Am Heart J 2007; 153: 22e1-22e8.

Online responses are no longer available. Please refer to our instructions for authors page for more information.